Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)
Clinical trial NCT01676831 · COMPLETED
Trial details
- NCT number
- NCT01676831
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2015-01-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.